Unknown

Dataset Information

0

Structural characterisation of the catalytic domain of botulinum neurotoxin X - high activity and unique substrate specificity.


ABSTRACT: Botulinum neurotoxins (BoNTs) are among the most potent toxins known and are also used to treat an increasing number of medical disorders. There are seven well-established serotypes (BoNT/A-G), which all act as zinc-dependent endopeptidases targeting specific members of the SNARE proteins required for synaptic vesicle exocytosis in neurons. A new toxin serotype, BoNT/X, was recently identified. It cleaves not only the canonical targets, vesicle associated membrane proteins (VAMP) 1/2/3 at a unique site, but also has the unique ability to cleave VAMP4/5 and Ykt6. Here we report the 1.35?Å X-ray crystal structure of the light chain of BoNT/X (LC/X). LC/X shares the core fold common to all other BoNTs, demonstrating that LC/X is a bona fide member of BoNT-LCs. We found that access to the catalytic pocket of LC/X is more restricted, and the regions lining the catalytic pocket are not conserved compared to other BoNTs. Kinetic studies revealed that LC/X cleaves VAMP1 with a ten times higher efficiency than BoNT/B and the tetanus neurotoxin. The structural information provides a molecular basis to understand the convergence/divergence between BoNT/X and other BoNTs, to develop effective LC inhibitors, and to engineer new scientific tools and therapeutic toxins targeting distinct SNARE proteins in cells.

SUBMITTER: Masuyer G 

PROVIDER: S-EPMC5851995 | biostudies-literature | 2018 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Structural characterisation of the catalytic domain of botulinum neurotoxin X - high activity and unique substrate specificity.

Masuyer Geoffrey G   Zhang Sicai S   Barkho Sulyman S   Shen Yi Y   Henriksson Linda L   Košenina Sara S   Dong Min M   Stenmark Pål P  

Scientific reports 20180314 1


Botulinum neurotoxins (BoNTs) are among the most potent toxins known and are also used to treat an increasing number of medical disorders. There are seven well-established serotypes (BoNT/A-G), which all act as zinc-dependent endopeptidases targeting specific members of the SNARE proteins required for synaptic vesicle exocytosis in neurons. A new toxin serotype, BoNT/X, was recently identified. It cleaves not only the canonical targets, vesicle associated membrane proteins (VAMP) 1/2/3 at a uniq  ...[more]

Similar Datasets

| S-EPMC3784703 | biostudies-literature
| S-EPMC6116196 | biostudies-literature
| S-EPMC8135040 | biostudies-literature
| S-EPMC2975405 | biostudies-literature
| S-EPMC9146395 | biostudies-literature
| S-EPMC2475686 | biostudies-literature
| S-EPMC5696347 | biostudies-literature
| S-EPMC4537209 | biostudies-literature
| S-EPMC7698808 | biostudies-literature
| S-EPMC8175023 | biostudies-literature